miR-210 inhibitor attenuated the “anti-cancer” effect of sevoflurane and HIF-1α expression induced by sevoflurane, and miR-138 or miR-335 inhibitors reversed the “anti-cancer” effect of desflurane and HIF-1α or MMP9 expressions induced by desflurane. The gene discussed is MMP9; the disease is cancer.